The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms
- 31 March 2001
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 98 (3) , 346-357
- https://doi.org/10.1006/clim.2000.4987
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient MiceThe Journal of Experimental Medicine, 1999
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- Interleukin-4 and listeriosisImmunological Reviews, 1997
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- NK1.1+ CD4+ CD8‐ thymocytes with specific lymphokine secretionEuropean Journal of Immunology, 1993
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice.The Journal of Experimental Medicine, 1992
- Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes.The Journal of cell biology, 1989
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987